The treatment of the "prostate syndrome" is a great challenge for the practicing veterinarian. In the present paper the therapeutic approach of this syndrome will be evaluated. 58 older dogs showing this syndrome were castrated and received thereafter oral antibiotic therapy. For further additional treatment the dogs were assigned to two groups. The groups were treated as follows: Group one: 41 dogs were treated with retard Gestagen and Flumethason infiltrated into the prostate gland tissue. Group two: 17 dogs were treated with a single subcutaneously applied Gestagen injection. The success of the therapy was judged by decrease the size of the prostate gland to normal size. The first evaluation took place after 2 weeks and the second one after a year following castration and treatment. At the time of the first judgement 95.1% of the dogs in the group one and 70.6% in the group two showed normal prostate gland size. At the time of the second examination, a year after the treatment still 82.8% of the dogs in the group one and only 52.8% in the group two showed normal prostate gland size. These results suggest that the infiltration of the enlarged prostate gland with retard acting Gestagen and Flumethason results in long lasting diminishing of size of the diseased gland.
|Number of pages||3|
|Journal||Berliner und Munchener Tierarztliche Wochenschrift|
|Publication status||Published - Dec 1 1997|
- Gestagenic agents
- Male dogs
- Prostate syndrome
ASJC Scopus subject areas